Purchase Order 75N92025P00229
Award Date
6/16/25
Potential Completion Date
12/16/25
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $24,940.00 and was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services. The contract is a Firm Fixed Price Purchase Order to provide the NHLBI's Sickle Cell Branch with the Olink assay, which will be used to study the profiling of plasma proteins among individuals with sickle cell disease. The contract has no set-aside designation and is...
This is a $24,940 firm-fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to Psomagen Inc., a genomics and molecular biology services company, to provide products for proteomic analysis on sickle cell plasma as part of ongoing sickle cell research efforts. The contract has an ultimate completion date of December 5, 2025. Psomagen Inc. is a subsidiary of Macrogen, Inc. and a for-profit manufacturer of goods that...
This is a $24,940 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Psomagen Inc., a for-profit manufacturer of goods. The contract is for high-throughput, sensitive, and specific protein quantification analysis to maintain the integrity of Batch 3 of sickle cell disease (SCD) patient samples for the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology....
This is a federal purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a genomics and molecular biology services company. The contract, valued at $15,344.80, is for Psomagen to provide OLINK EXPLORE HT (partial panel use) services to support next-generation sequencing-based proteomics analysis of plasma samples from hospitalized sepsis patients. The contract is not associated...
This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
This federal contract award to Psomagen Inc., a for-profit manufacturer, provides a Firm Fixed Price purchase order valued at $113,247.00 for the OLINK EXPLORE HT PROCESSING SERVICE. The contract is issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, and will support the institute's research on neurological disorders such as ALS, long COVID, and HIV. The contract requires Psomagen to perform the OLINK Explore HT Biomarker discovery protocol...
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $14,097.60 firm fixed price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide transcriptome profiling of human bone marrow core samples. The work supports the Hematology Branch at NHLBI. This is not a set-aside contract. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities. The company has a $500 million single-award Indefinite...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This federal contract award to Psomagen Inc., a for-profit organization and manufacturer, is for $48,825 to provide GENOTYPING SERVICES (DNA QC/MICROARRAY) to the National Institute on Aging, a civilian federal agency. The contract is a firm fixed-price purchase order with a performance period ending on January 6, 2026. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to support research and clinical applications. This contract is not...